Hologic People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More Hologic Strategic Plan Points to Long-Term Revenue Growth Driven by MDx Platforms, Tests Premium During its annual strategic planning, the firm identified its expanding base of MDx instruments as an essential driver of increasing revenues. Hologic Q3 Revenues Rise 42 Percent Despite Lower Demand for SARS-CoV-2 MDx Assays The company posted a 25 percent revenue growth in its diagnostics business but saw lower demand for its Panther and Panther Fusion SARS-CoV-2 tests. Hologic Obtains CE Mark for Use of Saliva With SARS-CoV-2 Molecular Test The firm noted that saliva as an alternative to other types of specimens should help facilitate screening in schools, workplaces, and other settings. Hologic Upgraded to Outperform by Evercore ISI Investors are refocusing on Hologic's base business given an anticipated major cut to COVID-19 industry testing revenues in fiscal year 2022, according to Evercore. Jun 23, 2021 Hologic Receives CE Mark for Molecular Test to Quantify Cytomegalovirus May 10, 2021 Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test May 5, 2021 US Department of Defense Awards $178.5M Contract to Hologic for SARS-CoV-2 Assays, Multiplex Tests Apr 30, 2021 Hologic Banking on MDx Acquisitions to Elevate Long-Term Revenue Growth Premium Apr 28, 2021 Hologic Q2 Revenues Climb 104 Percent on Continued COVID-19 Demand, Recovery of Base Businesses Apr 8, 2021 Hologic to Acquire Finnish MDx Firm Mobidiag for Approximately $795M Mar 8, 2021 With Diagenode Acquisition, Hologic Expects to Expand Panther Fusion Testing Menu Premium Mar 1, 2021 Hologic Acquires European MDx Firm Diagenode for Approximately $159M Jan 27, 2021 Hologic Fiscal Q1 Revenues Rise 89 Percent as Dx Testing Demand Surges Jan 20, 2021 Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines Jan 12, 2021 Hologic Looks to Expand Profile in Breast Cancer Testing With Biotheranostics Acquisition Premium Jan 12, 2021 JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher Jan 8, 2021 Hologic Preliminary Fiscal Q1 Revenues Rise 89 Percent on Coronavirus Testing Jan 5, 2021 Hologic to Acquire Molecular Diagnostics Firm Biotheranostics for $230M Dec 17, 2020 FDA Grants EUAs for Coronavirus Tests From Hologic, Genetworx, PacificDx Nov 20, 2020 Hologic Receives Additional FDA Approval for Diagnostic Use of HIV-1 Viral Load Test Nov 4, 2020 Hologic Fiscal Q4 Revenues Rise 56 Percent on Demand for SARS-CoV-2 Tests Nov 2, 2020 Hologic Wins $119M Contract From US Government to Expand COVID-19 Test Capacity Oct 6, 2020 FDA Revises Hologic Emergency Use Authorization to Include Asymptomatic Testing of SARS-CoV-2 Sep 28, 2020 Hologic Completes $950M Senior Notes Offering Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.